StockOtters
StockOttersSupply Chain Map

Sanofi

SNY

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
44,286
Cost of Revenue
13,205
Gross Profit
31,081
Gross Margin
70.2%
Operating Income
7,252
Operating Margin
16.4%
Net Income
5,560
Net Margin
12.6%
EPS (Basic)
$2.19
EPS (Diluted)
$2.19
EBITDA
11,033
EBITDA Margin
24.9%

2023

12/31/2023

Revenue
41,618
Cost of Revenue
12,628
Gross Profit
28,990
Gross Margin
69.7%
Operating Income
6,960
Operating Margin
16.7%
Net Income
5,400
Net Margin
13.0%
EPS (Basic)
$2.15
EPS (Diluted)
$2.15
EBITDA
11,390
EBITDA Margin
27.4%

2022

12/31/2022

Revenue
40,561
Cost of Revenue
11,882
Gross Profit
28,679
Gross Margin
70.7%
Operating Income
10,162
Operating Margin
25.1%
Net Income
8,371
Net Margin
20.6%
EPS (Basic)
$3.19
EPS (Diluted)
$3.18
EBITDA
13,510
EBITDA Margin
33.3%

2021

12/31/2021

Revenue
39,175
Cost of Revenue
12,255
Gross Profit
26,920
Gross Margin
68.7%
Operating Income
8,126
Operating Margin
20.7%
Net Income
6,223
Net Margin
15.9%
EPS (Basic)
$2.49
EPS (Diluted)
$2.49
EBITDA
11,538
EBITDA Margin
29.5%

2020

12/31/2020

Revenue
37,369
Cost of Revenue
12,159
Gross Profit
25,210
Gross Margin
67.5%
Operating Income
14,113
Operating Margin
37.8%
Net Income
12,294
Net Margin
32.9%
EPS (Basic)
$4.91
EPS (Diluted)
$4.91
EBITDA
17,883
EBITDA Margin
47.9%